The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of elotuzumab in combination with autologous stem cell transplantation and lenalidomide maintenance for multiple myeloma.
 
Keren Osman
No Relationships to Disclose
 
Hearn J. Cho
Honoraria - Genentech/Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Janssen Research & Development
Research Funding - Agenus; Bristol-Myers Squibb; Janssen Research & Development
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Ajai Chari
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Array Biopharma; Bayer; Celgene; Janssen Oncology; Millennium; Novartis; Seagen
Research Funding - Acetylon Pharmaceuticals (Inst); Array BioPharma; Biotest (Inst); Bristol-Myers Squibb (Inst); Celgene; Janssen; Millennium; Novartis; Onyx; Pharmacyclics
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Takeda
 
Samir S. Parekh
No Relationships to Disclose